RxDoctor Payments Data

Radhika Gollapudy, MD

Psychiatry · Columbus, OHNPI 1699858316

Payments from drug & device makers

$9,972in general payments, 2019–2025

Across 772 payments — averaging $12.92 each. Meals, travel, consulting and speaking fees, gifts and royalties reported by drug and device makers.

  • Teva Pharmaceuticals USA, Inc.$2K
  • Sunovion Pharmaceuticals Inc.$2K
  • Alkermes, Inc.$1K
  • AbbVie$1K
  • ITI, Inc. (d/b/a Intra-cellular Therapies, Inc.)$874
  • Otsuka America Pharmaceutical, Inc.$845
  • plus $2K from 7 others

What the payments were for

  • Food & beverage$9,64997%
  • Education$3203%
  • Gifts$30%

Most of this is food and beverage — typically meals provided during product presentations at a clinic or hospital. Nationally that is the single largest category of reported payments by count.

General payments by program year

19
20
21
22
23
24
25

Who reported the general payments

Companies are grouped under their corporate parent — a single manufacturer often files under several CMS reporting entities. Research and ownership payments are counted separately and are not in this table.

How this compares

$9,972 in reported general payments places this provider in the 90th percentile of 1,119 psychiatry providers in Ohio.

See all psychiatry providers in Ohio

Medicare billing

Part B allowed, 2024
$37,222
Medicare patients
44
Services billed
322

What this is not: this is the amount Original Medicare Part B allowed for services this provider billed in 2024. It is not their income. It excludes Medicare Advantage — now more than half of all Medicare enrollment — along with Medicaid and all commercial insurance, and it is gross practice revenue before staff, rent, supplies and malpractice premiums. CMS also suppresses any figure covering ten or fewer patients, so low-volume providers appear smaller than they are.

Most prescribed under Part D

DrugClaimsCost to plans & patients
Invega SustennaPaliperidone Palmitate103$300,007
Abilify MaintenaAripiprazole74$214,020
Austedo XrDeutetrabenazine22$98,467
Invega TrinzaPaliperidone Palmitate16$94,423
CaplytaLumateperone Tosylate30$50,605
VraylarCariprazine Hcl33$47,992
RexultiBrexpiprazole30$45,829
AristadaAripiprazole Lauroxil14$45,291
UzedyRisperidone13$36,710
Lurasidone Hcl152$32,956
Risperdal ConstaRisperidone Microspheres35$31,092
VivitrolNaltrexone Microspheres16$26,788
AuvelityDextromethorphan Hbr/Bupropion16$18,202
Paliperidone ErPaliperidone40$13,463
VyvanseLisdexamfetamine Dimesylate24$9,143

Paid to pharmacies, not to this prescriber.

Companies that both paid and supply prescribed drugs

These companies both reported payments to this provider and make drugs the provider prescribed under Medicare Part D in 2024. For most specialties this overlap is expected — a cardiologist who is paid by a cardiology drugmaker also treats heart disease. It is shown so the reader can see it, not because it implies anything on its own.

CompanyPaid to this providerPart D cost of their drugs
Johnson & JohnsonInvega Sustenna, Invega Trinza, Risperdal Consta$397$425,522154 claims
Otsuka America Pharmaceutical, Inc.Abilify Maintena, Rexulti$845$259,849104 claims
Teva Pharmaceuticals USA, Inc.Austedo Xr, Uzedy$2,247$135,17735 claims
Alkermes, Inc.Aristada, Vivitrol$1,339$72,07930 claims
ITI, Inc. (d/b/a Intra-cellular Therapies, Inc.)Caplyta$874$50,60530 claims
AbbVieVraylar$1,257$47,99233 claims
Axsome Therapeutics, Inc.Auvelity$701$18,20216 claims

Reading this fairly. The Part D column is what drug plans and patients paid pharmacies — this provider received none of it, and it reflects how many patients they treat and what those drugs cost. Against peers, this provider's reported payments sit in the 90th percentile of 1,119 psychiatry providers in Ohio.

Other psychiatry in Columbus

See the full list for Ohio

Where these figures come from

Is this you, or does something look wrong? →